The Future of Drug Delivery

Intellipharmaceutics is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs.

About Us

Unique and Validated Drug Delivery Technology

The flexibility and the competitive advantage of our proprietary technology allow us to focus our development activities in complex extended-release delivery systems.

Our Technology

A Pipeline that Spans from NDAs to ANDAs

Our product portfolio includes both new products and controlled-release generic products, and cover therapeutic areas that range from neurology, cardiovascular, gastrointestinal tract, diabetes and pain. We have developed several drug delivery systems and a pipeline of products (some of which have received FDA approval) and product candidates in various stages of development, including ANDAs filed with the FDA (and one ANDS filed with Health Canada) and one NDA filing.

Collaborative Development and Licensing Agreements

Our partnerships are driven by our goals to provide breakthrough technology with rewards and results in a highly competitive timeframe.

Become a Partner